Malignant Appendix Neoplasm — Trials

Malignant Appendix Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

72 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 28
Recruiting: 19
Ph III recruiting: 1
Growth YoY: —
Industry share: 7%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04902872	Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors	completed	Phase 1 / Phase 2	69	Cybrexa TherapeuticsINDUSTRY	1	Aug 20, 2026	clinicaltrials
NCT05185947	Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis	completed	Phase 2	21	National Cancer Institute (NCI)NIH	1	Jun 25, 2026	clinicaltrials